23.10.2014 Views

ARtrial 2 - College of Pharmacy - Idaho State University

ARtrial 2 - College of Pharmacy - Idaho State University

ARtrial 2 - College of Pharmacy - Idaho State University

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

C O L L E G E P R O G R A M S<br />

IDAHO DRUG UTILIZATION REVIEW PROGRAM<br />

The Omnibus Budget Reconciliation Act <strong>of</strong><br />

1990 (OBRA 90) requires that each state establish<br />

a drug utilization review (DUR) program for<br />

Medicaid outpatients. As a result <strong>of</strong> this federal<br />

mandate, the <strong>Idaho</strong> Department <strong>of</strong> Health and<br />

Welfare created the <strong>Idaho</strong> DUR Program. This<br />

program is designed to help enhance the quality<br />

<strong>of</strong> care for outpatients receiving prescription<br />

medications by assuring appropriate drug therapy.<br />

Currently the <strong>College</strong> <strong>of</strong> <strong>Pharmacy</strong> is the<br />

department’s agent for implementation <strong>of</strong> the<br />

OBRA 90 requirements regarding retrospective<br />

DUR.<br />

Retrospective DUR includes periodic<br />

examination <strong>of</strong> drug claims data and other<br />

records to identify prescribing and dispensing<br />

patterns. The screening includes comparing<br />

patient medication information against drug use<br />

criteria. Over the past seven years, the DUR staff<br />

has created explicit drug use criteria covering 20<br />

drug classes and approximately 200 <strong>of</strong> the most<br />

commonly prescribed drug products. These<br />

criteria represent standards or guidelines for<br />

appropriate drug use, as well as identifiable<br />

circumstances in which specific drug therapy entails<br />

a high risk for adverse effects. Employing the<br />

expertise <strong>of</strong> individual faculty members within<br />

the college, criteria were formulated using standard<br />

drug compendia and an extensive review <strong>of</strong> the<br />

clinical literature. Approximately 100 drug-specific<br />

criteria have been designated as potentially highcost<br />

or high-risk drug use situations in which<br />

communication with physicians and pharmacists<br />

is deemed necessary to alert them <strong>of</strong> potential<br />

problems.<br />

The following problem types are screened:<br />

age-drug contraindication, required use <strong>of</strong> generic<br />

drugs, drug-disease contraindications, drug-drug<br />

interactions, incorrect drug dosage, incorrect<br />

duration <strong>of</strong> drug treatment, over- and underutilization,<br />

as well as therapeutic duplication.<br />

THE DUR BOARD<br />

The Medicaid-appointed DUR Board is the<br />

decision-making body responsible for<br />

implementing and operating the DUR Program.<br />

Comprised <strong>of</strong> three practicing physicians, three<br />

practicing pharmacists, and one non-practicing<br />

physician the board is responsible for evaluating<br />

practitioner prescribing and dispensing behavior<br />

and determining<br />

appropriate<br />

educational or<br />

"...undergraduate &<br />

corrective<br />

graduate students have<br />

interventions. Data are<br />

been provided the<br />

reviewed by the DUR<br />

opportunity to address real<br />

staff and presented<br />

with recommended<br />

life problems by designing<br />

actions to the board<br />

computer s<strong>of</strong>tware &<br />

for approval or<br />

applications for use by<br />

modification. The<br />

health care practitioners &<br />

DUR staff is<br />

the community. "<br />

responsible for<br />

implementation <strong>of</strong> all<br />

board actions.<br />

ISU members <strong>of</strong> the 1999-00 DUR staff<br />

included: Vaughn Culbertson, Pharm.D., Project<br />

Director; Paul Cady, Ph.D., Data Management; Rex<br />

Force, Pharm.D., Research Director; Wendy Force,<br />

R.Ph., Clinical Specialist; Craig Kelley, B.S.,<br />

Computing; and Julie Johnson, Pharm.D.,<br />

Resident. Additionally, Dean Barbara G. Wells<br />

served at the board level as secretary.<br />

The board’s primary emphasis is educational,<br />

providing information concerning drug therapy to<br />

practitioners via pr<strong>of</strong>ile review, educational leaflets,<br />

and direct provider contact.<br />

PROVIDER EDUCATION<br />

The board, with recommendations from the<br />

DUR staff, approve all intervention strategies<br />

deemed necessary to improve the quality <strong>of</strong> care<br />

being delivered to <strong>Idaho</strong> Medicaid clients.<br />

Remedial strategies can include, but are not limited<br />

to:<br />

18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!